Floatz logo

Human Chorionic Gonadotropin

Polycystic Ovary Syndrome

Eman Basuni Ebrahim Mowadprotein_peptidePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
83/ 100
Competitive Position
73/ 100

Competitive context

60 Active assets in the Polycystic Ovary Syndrome cohort.

Asset / SponsorPhaseRating
Semaglutide
Methodist Health System
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
Follitropin Beta
Universitair Ziekenhuis Brussel
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Ege University
Phase 4BBB

View all 49 →

Same molecule, other indications

Human Chorionic Gonadotropin is also rated in:

infertility disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
endocrine system disorderDormant
BB
Indicative · Phase 3
69 / 100
View asset →
anovulationDormant
BB
Indicative · Phase 3
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →